Figure S5 from Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway

Autor: Tracy Robson, Robert B. Clarke, Eric O'Neill, Helen O. McCarthy, Stuart McIntosh, Adrien Kissenpfennig, Christopher Donley, Rachel Bennett, Hayley D. McKeen, Puthen V. Jithesh, Matthew P. Ablett, Hannah Harrison, Angelos Papaspyropoulos, Anita Yakkundi, Lana McClements
Rok vydání: 2023
DOI: 10.1158/1078-0432.22448493
Popis: Figure S5 - PDF file 48K, Figure S5. High FKBPL and low Nanog expression correlates with better DMFS and shows a trend towards better RFS. Samples with opposing FKBPL and Nanog expression (high FKBPL/low Nanog and low FKBPL/high Nanog) were analysed using microarray data from publically available data set (GSE7390). Samples were stratified based on median expression values of NANOG and FKBPL. Kaplan-Meier survival curves of breast cancer patients (n=94) presented
Databáze: OpenAIRE